Amar Kelkar MD MPH
amarkelkar.bsky.social
Amar Kelkar MD MPH
@amarkelkar.bsky.social
BMT, Gene Therapy, & Hematology Physician at Dana-Farber Cancer Institute, Brigham & Women's Hospital, and Harvard Medical School | AI, Health Policy, Health Economics, & Ethics research | T.H. Chan Harvard MPH ‘23 | SGU '15 | Cornell ‘10
10/ The MFN policy reflects urgency—but not durability or long-term strategy. With the right reforms, Medicare negotiation can do better: lower prices faster, fairer, and without derailing innovation.

@eddiecliff.bsky.social

📰 Full Viewpoint at @jama.com:
jamanetwork.com/journals/jam...
July 29, 2025 at 6:12 AM
The House of Representatives is voting into the night on a massive House Resolution (HR) 1 that will result in 16 million losing healthcare coverage (~11 million on Medicaid, and ~5 million from ACA marketplaces). Call your Congressperson's office tonight and tell them to vote NO!
July 3, 2025 at 3:21 AM
We need responsible reform of NIH funding (streamlining regulations!), NOT devastating cuts. Let's protect the engine of US medical innovation. 🇺🇸🔬 #ResearchMatters
6/6
May 8, 2025 at 4:00 AM
The proposed 15% ICR cap is a drastic cut 📉, much deeper than it appears due to how ICRs are actually calculated (ICR=indirect/direct) that come out to 50-60% in practice at many major institutions! This will lead to significant funding losses for institutions. 💰➡️0
3/6
May 8, 2025 at 4:00 AM
Indirect costs in federal grants aren't just "overhead"! They cover essential research infrastructure: labs 🧪, equipment 🔬, admin support 🧑‍💼, compliance, safety & tech transfer. These are INTEGRAL to responsible research.
2/6
May 8, 2025 at 4:00 AM
I swear we didn’t pose this 😆 but now all I can think of is the Spiderman pointing meme …
December 7, 2024 at 3:51 AM